Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Express Scripts
Medtronic
McKinsey

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 9,388,243

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,388,243
Title:Method of target membrane protein depletion
Abstract: A method of target membrane protein depletion comprising treating a cell with a dual binding molecule comprising a first binding domain which binds to a driver membrane protein and a second binding domain which binds to a target membrane protein, wherein the cell comprises a cell membrane, and the driver membrane protein and target membrane protein are associated with the cell membrane where the target membrane protein positions, and are internalized into a cell and degraded when the first binding domain of the dual binding molecule binds the driver membrane protein; as well as related methods and compositions.
Inventor(s): Cheong; Kwang Ho (Seoul, KR), Lee; Seung Hyun (Suwon-si, KR), Cho; Mi Young (Seoul, KR), Koh; Young Jun (Yongin-si, KR), Powei; Lin (Hwaseong-si, KR), Yi; Christina (Seongnam-si, KR), Hwang; Jae Woong (Seoul, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR)
Application Number:14/290,447
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,388,243
Patent Claims:see list of patent claims

Details for Patent 9,388,243

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 1998-09-25 ⤷  Try it Free 2033-05-29
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 2017-02-10 ⤷  Try it Free 2033-05-29
Eli Lilly And Company ERBITUX cetuximab Injection 125084 2004-02-12 ⤷  Try it Free 2033-05-29
Eli Lilly And Company ERBITUX cetuximab Injection 125084 2007-03-28 ⤷  Try it Free 2033-05-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Medtronic
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.